Pfizer to invest in Israeli incubator

NEW YORK Pfizer will be investing in Israel’s Meytav Technological Enterprises Innovation Center, according to reports.

Pfizer will invest in and establish a second incubator in Galilee, according to Israeli business daily Globes. Israel, the Globes report said, would have to adjust its intellectual property protection laws before international pharmaceutical companies would launch activity there.

Meytav executives will be responsible for the joint activity with Pfizer.